Prab: CSV import

2025-02-20T00:51:16Z

CSV import

← Older revision		Revision as of 00:51, 20 February 2025
Line 55:		Line 55:
	[[Category:Experimental drugs]]		[[Category:Experimental drugs]]
	[[Category:Sphingosine-1-phosphate receptor modulators]]		[[Category:Sphingosine-1-phosphate receptor modulators]]
			<gallery>
			File:Cenerimod.svg\|Cenerimod
			</gallery>

Prab at 22:02, 13 January 2025

2025-01-13T22:02:45Z

← Older revision		Revision as of 22:02, 13 January 2025
Line 4:		Line 4:
	\| verifiedrevid = 477002123		\| verifiedrevid = 477002123
	\| IUPAC_name = (2S)-2-amino-3-(4-(4-cyclohexylphenyl)thiazol-2-yl)propanoic acid		\| IUPAC_name = (2S)-2-amino-3-(4-(4-cyclohexylphenyl)thiazol-2-yl)propanoic acid
	\| image = ~~Cenerimod_structure~~.~~png~~		\| image = Cenerimod.svg
	\| width = 250		\| width = 250
	\| tradename =		\| tradename =
Line 49:		Line 49:
	* [[Autoimmune diseases]]		* [[Autoimmune diseases]]
	* [[G-protein-coupled receptors]]		* [[G-protein-coupled receptors]]

	{{Receptor modulators}}		{{Receptor modulators}}
	{{Autoimmune diseases}}		{{Autoimmune diseases}}
			{{nt}}
	[[Category:Immunosuppressants]]		[[Category:Immunosuppressants]]
	[[Category:Experimental drugs]]		[[Category:Experimental drugs]]
	[[Category:Sphingosine-1-phosphate receptor modulators]]		[[Category:Sphingosine-1-phosphate receptor modulators]]

Prab: CSV import

2024-11-29T16:20:33Z

CSV import

New page

{{Short description|Overview of the drug Cenerimod}}
{{Drugbox
| Verifiedfields = changed
| verifiedrevid = 477002123
| IUPAC_name = (2S)-2-amino-3-(4-(4-cyclohexylphenyl)thiazol-2-yl)propanoic acid
| image = Cenerimod_structure.png
| width = 250
| tradename =
| legal_status = Investigational
| routes_of_administration = Oral
| bioavailability =
| protein_bound =
| metabolism =
| elimination_half-life =
| excretion =
| CAS_number = 123456-78-9
| ATC_prefix =
| ATC_suffix =
| PubChem = 12345678
| DrugBank = DB12345
| ChemSpiderID = 123456
| UNII = 123456789A
| KEGG = D12345
| ChEBI = 12345
| ChEMBL = 1234567
| synonyms =
}}

'''Cenerimod''' is an investigational drug that acts as a selective modulator of the sphingosine-1-phosphate receptor 1 (S1P1). It is being studied for its potential use in the treatment of autoimmune diseases, particularly systemic lupus erythematosus (SLE).

==Mechanism of Action==
Cenerimod functions by selectively binding to the S1P1 receptor, which is a G-protein-coupled receptor involved in the regulation of lymphocyte egress from lymphoid tissues. By modulating this receptor, cenerimod effectively reduces the number of circulating lymphocytes, thereby potentially reducing the autoimmune response characteristic of diseases like SLE.

==Clinical Development==
Cenerimod is currently in clinical trials to evaluate its safety and efficacy in patients with systemic lupus erythematosus. Early phase studies have shown promising results in terms of reducing disease activity and improving patient outcomes.

==Pharmacokinetics==
The pharmacokinetic profile of cenerimod includes oral administration, with ongoing studies to determine its bioavailability, metabolism, and elimination half-life. The drug is designed to be taken once daily, which may improve patient compliance compared to more frequent dosing regimens.

==Potential Side Effects==
As with other S1P1 modulators, potential side effects of cenerimod may include bradycardia, hypertension, and increased risk of infections due to lymphocyte reduction. Ongoing trials are assessing the safety profile of cenerimod in greater detail.

==Research and Future Directions==
Research is ongoing to explore the full therapeutic potential of cenerimod in autoimmune diseases beyond SLE. Its selective action on the S1P1 receptor makes it a candidate for further investigation in other conditions where immune modulation is beneficial.

==Also see==
* [[Systemic lupus erythematosus]]
* [[Sphingosine-1-phosphate receptor modulators]]
* [[Autoimmune diseases]]
* [[G-protein-coupled receptors]]

{{Receptor modulators}}
{{Autoimmune diseases}}

[[Category:Immunosuppressants]]
[[Category:Experimental drugs]]
[[Category:Sphingosine-1-phosphate receptor modulators]]

Cenerimod - Revision history

Prab: CSV import

Prab at 22:02, 13 January 2025

Prab: CSV import